Five ways in which US FDA will bolster device surveillance
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration plans to focus on five key projects this year to strengthen the post-market surveillance of medical devices, including finalizing the agency's much-awaited unique device identification rule.